Xunfei Healthcare Technology Co., Ltd.
HHKEX:250665.75
HKD
-0.60
(-0.90%)
ISIN
CNE100006MP5
Return %
Stock
S&P 500
1Y
-25.87
14.20
3Y
- -
81.12
5Y
- -
68.34
Capital Structure
CNY
•
in mil. unless spec.Working Capital
CNY
•
in mil. unless spec.Growth Rates
CNY
•
in mil. unless spec.Semi-annual Revenue
CNY
•
in mil. unless spec.Semi-annual Earnings Per Share
CNY
•
in mil. unless spec.Semi-annual Dividends Per Share
CNY
•
in mil. unless spec.Company Description
- CEO
- Xiao Dong Tao
- Full Time Employees
- 1,045
- Sector
- Technology services
- Industry
- Information technology services
- Address
- FLYTEK AI Research and Development Production Base (Phase I) Hefei AN China 230088
- IPO Date
- Dec 30, 2024
- Website
- iflyhealth.com
- Similar Companies
- Business
- Xunfei Healthcare Technology Co., Ltd. (Ticker: 2506.HK) engages in AI-enabled healthcare solutions, delivering a broad suite of products and services across core healthcare IT, hospital, and patient care ecosystems. Main Products and Services - AI-powered clinical decision support and language processing tools: general practice and specialty CDSS, complex medical language comprehension, disease diagnosis and treatment recommendations, professional documentation generation, multi-round medical dialogues, and multi-modal medical interactions; integrated into EMR/QMS workflows to assist clinicians and improve diagnostic and treatment decision quality. - Post-discharge patient management and continuity of care: post-discharge management platform including mobile apps and mini programs, patient engagement and follow-up tools, automated reminders, and personalized recovery plans; supports continuity of care and chronic disease management. - Cloud medical imaging platform: remote imaging processing, storage, and viewing capabilities; enables cloud-based analysis and reporting to support radiology workflows. - Intelligent hardware and devices: medical devices and peripherals aligned with AI-enabled workflows; designed to capture, transmit, and analyze patient data for clinical use. - Smart hospital solutions: intelligent patient triage systems, electronic medical record (EMR) generation tools (speech-to-text and AI-assisted documentation), and hospital-wide AI-enabled productivity and decision-support capabilities. - Regional healthcare solutions: healthcare administrator services and medical insurance administration tooling, enabling streamlined operations and analytics across regional health networks. - AI-powered imaging and diagnostic tools: medical imaging analytics, diagnostic assistants, and imaging workflow optimization to improve radiology throughput and accuracy. - AI-based patient data integration and analytics: data ingestion from disparate sources, EMR quality control, and evidence-based clinical knowledge integration to support care pathways and outcomes measurement. - Medical insurance and reimbursement solutions: solutions to support claim processing, eligibility verification, and value-based care programs within health networks. Latest Major Company Changes - Strategic partnerships and alliances: enters collaborations to deepen AI-enabled healthcare offerings and expand regional smart imaging capabilities, enhancing research and development in AI-driven medical imaging diagnostics; these partnerships broaden deployment across networks and accelerate commercialisation of cognitive imaging solutions. - Acquisitions and funding activity: engages in capital-raising and potential acquisitions to augment AI model capabilities, expand hospital solutions portfolio, and strengthen post-discharge management platforms; these activities reinforce growth and scale. - Product and platform upgrades: delivers major upgrades to AI models and platforms, including improvements in medical Q&A, complex language understanding, professional document generation, disease diagnosis and treatment recommendations, multi-round medical dialogues, and multi-modal medical interactions; upgrade enhances overall effectiveness and supports post-discharge patient management with enhanced EMR analysis and personalized recovery plans. - Market and regulatory expansions: enhances regional healthcare solutions and medical insurance administration tools to support broader geographic implementation and regulatory compliance; expands presence in domestic markets and seeks scalable deployments. Additional Context - Industry and segments: health tech, AI in healthcare, clinical decision support, hospital IT, patient management platforms, cloud imaging, medical devices. - Target customers: hospitals, clinics, regional health authorities, medical insurers, ambulatory care providers, and patients requiring chronic disease management. - Geographic operations: primarily focused on the domestic Chinese market with broader regional healthcare solutions, and potential expansion into international health networks and partnerships. - Founding year and headquarters: established in 2016; subsidiary of a leading AI technology group; headquarters located in China, with significant operations and partnerships in domestic markets. - Subsidiaries/parent relationships: operates as a subsidiary under the larger AI technology group; maintains strategic collaborations with regional healthcare entities and insurance providers to deliver integrated AI-enabled health solutions. Note: The above description reflects publicly reported information on Xunfei Healthcare Technology Co., Ltd. (2506.HK) including its AI-driven healthcare platform, post-discharge care offerings, imaging and hospital solutions, and recent strategic partnerships and platform upgrades aimed at expanding its AI-enabled healthcare ecosystem.